Oak Street Health Upgraded at Raymond James on CVS Takeover Interest
UBS Adjusts CareMax's Price Target to $6 From $10, Maintains Buy Rating
10:12 AM EST, 01/06/2023 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may co
UBS Group Cuts CareMax (NASDAQ:CMAX) Price Target to $6.00
CareMax (NASDAQ:CMAX – Get Rating) had its price target dropped by stock analysts at UBS Group from $10.00 to $6.00 in a research report issued on Friday, Benzinga reports. The brokerage presently h
CareMax Price Target Cut to $6.00/Share From $10.00 by UBS
CareMax Price Target Cut to $6.00/Share From $10.00 by UBS
CareMax Is Maintained at Buy by UBS
UBS Maintains Buy on CareMax, Lowers Price Target to $6
UBS analyst Andrew Mok maintains CareMax (NASDAQ:CMAX) with a Buy and lowers the price target from $10 to $6.
CareMax Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 01/06/2023 71.43% UBS $10 → $6 Maintains Buy 09/07/2022 114.29% Truist Securities → $7.5 Initiates Coverag
CareMax, Inc. to Present at the 41st Annual J.P. Morgan Healthcare Conference
CareMax, Inc. ("CareMax") (NASDAQ:CMAX, CMAXW)), a leading technology-enabled provider of value-based care to seniors, announced today that Chief Executive Officer Carlos de Solo, Chief Operating Officer Albert de Solo,
CareMax (NASDAQ:CMAX) Shareholders Have Endured a 52% Loss From Investing in the Stock a Year Ago
CareMax (NASDAQ:CMAX) One-year Losses Have Grown Faster Than Shareholder Returns Have Fallen, but the Stock Jumps 16% This Past Week
CareMax, Inc. (NASDAQ:CMAX) shareholders should be happy to see the share price up 16% in the last week. But that isn't much consolation to those who have suffered through the declines of the last
Loading...
No Stock Yet